Recent changes to medicines optimisation dashboard including infliximab biosimilar metric -

Recent changes to medicines optimisation dashboard including infliximab biosimilar metric
Information type: Drug/medicines management
Source: NHS England
Specialities:
Summary
Further to first full revision of dashboard in November 2015, where more up to date data are available, the data for metrics have been refreshed following feedback. Users should click on the ‘Changes’ tab within the dashboard to find out which metrics have been updated.
UKMi comment
A new metric in the medicines optimisation dashboard is the percentage of the total infliximab used for both the originator biological medicine and biosimilar versions by volume.
Related links: